These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9358876)
1. ADH and oxytocin in age-related minor cognitive impairment. Legros JJ Aging (Milano); 1997; 9(4 Suppl):36-7. PubMed ID: 9358876 [No Abstract] [Full Text] [Related]
2. [Indication for treatment of women with oxytocin and vasopressin]. Klimek R Ginekol Pol; 1968 Mar; 39(3):367-71. PubMed ID: 5652034 [No Abstract] [Full Text] [Related]
7. [The decrease of hemorrhages in vaginal hysterectomies through administration of adrenaline, octapressine, Por-8 and Pox-85]. Nosan M; Novak F; Mazovec M Gynaecologia; 1968; 165(1):21-30. PubMed ID: 5646964 [No Abstract] [Full Text] [Related]
8. [On the problems of synthetic polypeptides on the basis of oxytocin]. Holecek V Vnitr Lek; 1969 May; 15(5):435-41. PubMed ID: 5792536 [No Abstract] [Full Text] [Related]
9. [Vasopressin and Oxytocin. Physiological and pharmacological basis for the clinical use of the posterior pituitary gland hormones]. Rauch R Dtsch Med Wochenschr; 1969 Dec; 94(50):2611-4. PubMed ID: 4901915 [No Abstract] [Full Text] [Related]
10. Modulation of memory by pituitary hormones and related peptides. Rigter H; Crabbe JC Vitam Horm; 1979; 37():153-241. PubMed ID: 232793 [No Abstract] [Full Text] [Related]
11. Social effects of oxytocin in humans: context and person matter. Bartz JA; Zaki J; Bolger N; Ochsner KN Trends Cogn Sci; 2011 Jul; 15(7):301-9. PubMed ID: 21696997 [TBL] [Abstract][Full Text] [Related]
12. Neurohypophyseal aging: differential changes in oxytocin and vasopressin release, studied in Fischer 344 and Sprague-Dawley rats. Zbuzek V; Fuchs AR; Zbuzek VK; Wu WH Neuroendocrinology; 1988 Dec; 48(6):619-26. PubMed ID: 3251161 [TBL] [Abstract][Full Text] [Related]
13. [Pregnancy and delivery in diabetes insipidus]. Jakubowska D; Niedworok H; Pepich W Zentralbl Gynakol; 1968 Sep; 90(38):1301-4. PubMed ID: 5725675 [No Abstract] [Full Text] [Related]
14. [The role of oxytocin and vasopressin in central nervous system activity and mental disorders]. Wójciak P; Remlinger-Molenda A; Rybakowski J Psychiatr Pol; 2012; 46(6):1043-52. PubMed ID: 23479945 [TBL] [Abstract][Full Text] [Related]
15. The effects of oxytocin on cognitive defect caused by chronic restraint stress applied to adolescent rats and on hippocampal VEGF and BDNF levels. Dayi A; Cetin F; Sisman AR; Aksu I; Tas A; Gönenc S; Uysal N Med Sci Monit; 2015 Jan; 21():69-75. PubMed ID: 25559382 [TBL] [Abstract][Full Text] [Related]
16. Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia. Rubin LH; Wehring HJ; Demyanovich H; Sue Carter C; Pournajafi-Nazarloo H; Feldman SM; Earl AK; August S; Gold JM; Kelly DL Schizophr Res; 2018 May; 195():409-411. PubMed ID: 28965776 [No Abstract] [Full Text] [Related]
17. The impact of drugs against dementia on cognition in aging and mild cognitive impairment. Ihl R Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S38-43. PubMed ID: 13130387 [TBL] [Abstract][Full Text] [Related]
19. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia. Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169 [TBL] [Abstract][Full Text] [Related]